ArticleAnnals of medicine and surgery (2012)2026
Acquired cystic disease-associated renal cell carcinoma: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: This article presents a case study to explore the etiology, pathology, radiological features, treatment, and prognosis of acquired cystic disease-associated renal cell carcinoma (ACD-RCC). Case presentation: An elderly male patient with a 13-year history of regular dialysis due to renal failure was admitted to the hospital presenting with hematuria lasting for 2 weeks. Following surgery, a tumor was identified within the renal parenchyma, and pathological analysis confirmed the diagnosis of ACD-RCC. Clinical Discussion: ACD-RCC is relatively rare and characterized by distinctive clinical and pathological manifestations. This condition typically occurs in patients with prolonged dialysis history. Microscopic examination commonly reveals characteristic calcium oxalate crystals, and immunohistochemical analyses typically demonstrate the expression of specific markers such as P504S and CD10. Conclusion: ACD-RCC is an extremely rare kidney tumor seen mainly in patients with end-stage renal disease. Regular imaging monitoring is crucial for long-term dialysis patients, particularly those who are young and minimally symptomatic. Upon detecting a lesion, a prompt pathological examination should be conducted to determine the lesion's nature, followed by early intervention to improve prognosis and life quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.